Beijing Balance Medical Technology Co., Ltd. (688198.SH): The registration application for pericardial membrane (ePTFE) has been accepted, potentially breaking the monopoly of foreign companies and achieving independent and controllable domestic production.

Beijing Balance Medical Technology Co., Ltd. (688198.SH) announced that the registration application for the company's ePTFE pericardium has been officially accepted by the National Medical Products Administration. This product is a porous polytetrafluoroethylene (ePTFE) membrane manufactured using special techniques, used for repairing or reconstructing pericardium in cardiac surgery. It is reported that the pericardial membranes currently used in the domestic market are all monopolized by foreign companies, relying on imports for a long time. The registration and listing of this product are expected to end the history of full import of ePTFE implant materials in cardiac surgery, realizing domestic independent and controllable production.